odronextamab
regeneron
['odronextamab', 'lymsm']
odronextamab, a human cd20 cd3 bispecific antibody in patients with cd20-positive b-cell malignancies (elm-1) #ash22 #lymsm 
Chief, Adult Bone Marrow Transplant Service @MSKCancerCenter President-Elect @ASTCT Past Board Member @BeTheMatch  Transplant Comm Chair @ALLIANCE_org